EMR vs Guinea: Hepatitis B surface antigen (HBsAg) prevalence (%)
EMR
0.5%
in 2024
Guinea
2.8%
in 2024
EMR rank
4th
Guinea rank
7th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- EMR
- Guinea
How they compare
Guinea currently reports 2.8% against 0.5% in EMR, a difference of 2.3%.
That makes Guinea's figure about 5.6 times EMR's.
Across all 10 years both countries report, Guinea has been ahead every year.
EMR ranks 4th and Guinea ranks 7th of 13 groups.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | EMR | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 2.7% | 2.2% | Guinea |
| 2020s | 0.5% | 2.7% | 2.2% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, EMR or Guinea?
- Guinea, at 2.8% against 0.5% in EMR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between EMR and Guinea?
- 2.3%, with Guinea ahead.
- How many years of comparable data are there for EMR and Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do EMR and Guinea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- EMR ranks 4th and Guinea ranks 7th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.